How were TransAtlantic Petroleum's earnings last quarter?

TransAtlantic Petroleum Ltd. (NYSEAMERICAN:TAT) posted its quarterly earnings results on Monday, March, 16th. The oil and natural gas company reported $0.39 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.24. The oil and natural gas company had revenue of $29.94 million for the quarter, compared to the consensus estimate of $36.30 million.

What other stocks do shareholders of TransAtlantic Petroleum own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TransAtlantic Petroleum investors own include Gran Tierra Energy (GTE) , CNBX Pharmaceuticals (CNBX) , Pennsylvania Real Estate Investment Trust (PEI) , Aeterna Zentaris (AEZS) , Bionano Genomics (BNGO) , Hallador Energy (HNRG) , ADMA Biologics (ADMA) , Matinas BioPharma (MTNB) , Zosano Pharma (ZSAN) .

How do I buy shares of TransAtlantic Petroleum?

Shares of TAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEAMERICAN:TAT

TransAtlantic Petroleum (TAT) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free TAT Stock Alerts

$0.25

0.00 (0.00%)

(As of 09/17/2021)

Compare

Today's Range: $0.25
▼
$0.25
50-Day Range: N/A
52-Week Range: $0.12
▼
$0.84

Volume: N/A
Average Volume: 1.56 million shs
Market Capitalization: $18.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get TransAtlantic Petroleum alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About TransAtlantic Petroleum Stock (NYSEAMERICAN:TAT)

TransAtlantic Petroleum Ltd., an oil and natural gas company, engages in the acquisition, exploration, development, and production of oil and natural gas properties in Turkey and Bulgaria. As of December 31, 2019, it had interests in 4 onshore exploration licenses and 20 onshore production leases covering an area of 436,388 net acres with a total net proved reserves of 10,259 thousand barrels of oil and 2,466 million cubic feet of natural gas located in Turkey, as well as a production concession covering an area of approximately 162,800 net undeveloped acres located in Bulgaria. The company was incorporated in 1985 and is based in Addison, Texas.

TAT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TAT Stock News Headlines

September 26, 2023 | bizjournals.com

Breaking: San Antonio International Airport lands first transatlantic flights

October 2, 2022 | investopedia.com

Transatlantic Trade and Investment Partnership (TTIP)

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

March 31, 2022 | uk.finance.yahoo.com

Cathay plans world's longest passenger flight, avoids Russian airspace

See More Headlines

Receive TAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransAtlantic Petroleum and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/16/2015
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Sector: Basic Materials
Industry: Oil & Gas Drilling & Exploration
Sub-Industry: N/A
Current Symbol: NYSEAMERICAN:TAT
Previous Symbol: NYSE:TAT
CUSIP: N/A
CIK: 1092289
Web: www.transatlanticpetroleum.com
Phone: (214) 220-4323
Fax: N/A
Employees: 147
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 76,336,000
Free Float: N/A
Market Cap: $18.78 million
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. N. Malone Mitchell III (Age 58)
Chairman & CEO
Comp: $2M
Mr. Selami Erdem Uras (Age 62)
Exec. VP of Turkey
Comp: $638.03k
Mr. Todd C. Dutton (Age 66)
Pres
Mr. Michael Paul Hill (Age 39)
Principal Accounting & Financial Officer and Chief Accounting Officer
Mr. Veli Ozan Ãlker
Chief Financial Officer of Eastern Europe
Mr. Noah Malone Mitchell IV
VP

Key Competitors

View All Competitors

TAT Stock Analysis - Frequently Asked Questions

How were TransAtlantic Petroleum's earnings last quarter?: TransAtlantic Petroleum Ltd. (NYSEAMERICAN:TAT) posted its quarterly earnings results on Monday, March, 16th. The oil and natural gas company reported $0.39 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.24. The oil and natural gas company had revenue of $29.94 million for the quarter, compared to the consensus estimate of $36.30 million.
What other stocks do shareholders of TransAtlantic Petroleum own?: Based on aggregate information from My MarketBeat watchlists, some companies that other TransAtlantic Petroleum investors own include Gran Tierra Energy (GTE), CNBX Pharmaceuticals (CNBX), Pennsylvania Real Estate Investment Trust (PEI), Aeterna Zentaris (AEZS), Bionano Genomics (BNGO), Hallador Energy (HNRG), ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN).
How do I buy shares of TransAtlantic Petroleum?: Shares of TAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:TAT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial